Use of GM-CSF to inhibit development of drug resistance in HIV+ patients
A Standard patent application filed on 22 October 1999 credited to Gilbert, Mark J.

Details

Application number :
12252  
Application type :
Standard  
Application status :
CEASED  
Under opposition :
No  
Proceeding type :
 
Invention title :
Use of GM-CSF to inhibit development of drug resistance in HIV+ patients  
Inventor :
Gilbert, Mark J.  
Agent name :
Davies Collison Cave  
Address for service :
GPO Box 3876 SYDNEY NSW 2001  
Filing date :
22 October 1999  
Associated companies :
 
Applicant name :
Schering Aktiengesellschaft  
Applicant address :
Mullerstrasse 178 D-13353 Berlin Germany  
Old name :
Immunex Corporation  
Original Source :
Go  

Same Inventor